eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR: eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
moreShow EFTR Financials
Recent trades of EFTR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EFTR's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Compositions and methods for an improved antitumor immune response Feb. 14, 2023
-
Patent Title: Methods and compositions for cellular immunotherapy Jan. 31, 2023
-
Patent Title: Eif4a-inhibiting compounds and methods related thereto Sep. 13, 2022
-
Patent Title: Eif4e-inhibiting compounds and methods Mar. 29, 2022
-
Patent Title: Crystalline forms of mnk inhibitors Sep. 28, 2021
-
Patent Title: Piperidine-substituted mnk inhibitors and methods related thereto Aug. 10, 2021
-
Patent Title: Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit mnk1 and mnk2 May. 25, 2021
-
Patent Title: Benzimidazole-indole inhibitors of mnk1 and mnk2 Oct. 06, 2020
-
Patent Title: Methods and compositions for cellular immunotherapy Sep. 22, 2020
-
Patent Title: Inhibitors of immune checkpoint modulators and related methods Jul. 07, 2020
-
Patent Title: Eif4a-inhibiting compounds and methods related thereto Mar. 03, 2020
-
Patent Title: Compositions and methods for treating fibrotic disease Mar. 03, 2020
-
Patent Title: Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of mnk1 and mnk2 Oct. 30, 2018
-
Patent Title: Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers Jun. 19, 2018
-
Patent Title: Compositions and methods for treating fibrotic disease Jun. 12, 2018
-
Patent Title: Eif4a-inhibiting compounds and methods related thereto May. 01, 2018
-
Patent Title: Mnk inhibitors and methods related thereto Nov. 14, 2017
-
Patent Title: Mnk inhibitors and methods related thereto Jun. 06, 2017
-
Patent Title: Mnk inhibitors and methods related thereto Jul. 05, 2016
Federal grants, loans, and purchases
Followers on EFTR's company Twitter account
Number of mentions of EFTR in WallStreetBets Daily Discussion
Recent insights relating to EFTR
Recent picks made for EFTR stock on CNBC
ETFs with the largest estimated holdings in EFTR
Flights by private jets registered to EFTR